Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 40 results.
User Information
Export Records
  1. 1.   Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome
  2. Childs, Richard W; Tian, Xin; Vo, Phuong; Purev, Enkhtsetseg; Kotecha, Ritesh R; Carlsten, Mattias; Clara, Joseph; Flegel, Willy A; Adams, Sharon D; Khuu, Hanh M; Stroncek, David F; Cook, Lisa; Worthy, Tat'yana; Geller, Nancy L; Wells, Brian; Wilder,Jennifer; Reger, Robert; Aue, Georg
  3. British Journal of Haematology. 2021, May 15; 193(5): 951-960.
  1. 2.   Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2
  2. Wang, W.; Erbe, A. K.; Gallenberger, M.; Kim, K.; Carmichael, L.; Hess, D.; Mendonca, E. A.; Song, Y.; Hank, J. A.; Cheng, S. C.; Signoretti, S.; Atkins, M.; Carlson, A.; Weiss, J. M.; Mier, J.; Panka, D.; McDermott, D. F.; Sondel, P. M.
  3. Cancer immunology, immunotherapy : CII. 2016, Dec; 65(12): 1523-1532.
  1. 3.   Diversity of the KIR gene cluster in an urban Brazilian population
  2. Augusto, D. G.; Zehnder-Alves, L.; Pincerati, M. R.; Martin, M. P.; Carrington, M.; Petzl-Erler, M. L.
  3. Immunogenetics. 2012, Feb; 64(2): 143-152.
  1. 4.   Analysis of Binding of KIR3DS1*014 to HLA Suggests Distinct Evolutionary History of KIR3DS1
  2. O'Connor, G. M.; Yamada, E.; Rampersaud, A.; Thomas, R.; Carrington, M.; McVicar, D. W.
  3. Journal of Immunology. 2011, Sep; 187(5): 2162-2171.
  1. 5.   Design, expression and characterization of a soluble single-chain functional human neonatal Fc receptor
  2. Feng, Y.; Gong, R.; Dimitrov, D. S.
  3. Protein Expression and Purification. 2011, Sep; 79(1): 66-71.
  1. 6.   Shortened Engineered Human Antibody CH2 Domains INCREASED STABILITY AND BINDING TO THE HUMAN NEONATAL Fc RECEPTOR
  2. Gong, R.; Wang, Y. P.; Feng, Y.; Zhao, Q.; Dimitrov, D. S.
  3. Journal of Biological Chemistry. 2011, Aug; 286(31): 27288-27293.
  1. 7.   Killer Immunoglobulin-Like Receptor Transcriptional Regulation: A Fascinating Dance of Multiple Promoters
  2. Cichocki, F.; Miller, J. S.; Anderson, S. K.
  3. Journal of Innate Immunity. 2011, Apr; 3(3): 242-248.
  1. 8.   KIR Polymorphisms Modulate Peptide-Dependent Binding to an MHC Class I Ligand with a Bw6 Motif
  2. Colantonio, A. D.; Bimber, B. N.; Neidermyer, W. J.; Reeves, R. K.; Alter, G.; Altfeld, M.; Johnson, R. P.; Carrington, M.; O'Connor, D. H.; Evans, D. T.
  3. Plos Pathogens. 2011, Mar; 7(3): 13.
  1. 9.   Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2
  2. Hiby, S. E.; Apps, R.; Sharkey, A. M.; Farrell, L. E.; Gardner, L.; Mulder, A.; Claas, F. H.; Walker, J. J.; Redman, C. C.; Morgan, L.; Tower, C.; Regan, L.; Moore, G. E.; Carrington, M.; Moffett, A.
  3. Journal of Clinical Investigation. 2010, Nov; 120(11): 4102-4110.
  1. 10.   Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex
  2. Traherne, J. A.; Martin, M.; Ward, R.; Ohashi, M.; Pellett, F.; Gladman, D.; Middleton, D.; Carrington, M.; Trowsdale, J.
  3. Human Molecular Genetics. 2010, Mar; 19(5): 737-751.
  1. 11.   Pathogenesis of Hyper IgE Syndrome
  2. Heimall, J.; Freeman, A.; Holland, S. M.
  3. Clinical Reviews in Allergy & Immunology. 2010, Feb; 38(1): 32-38.
  1. 12.   HLA Class I Subtype-Dependent Expansion of KIR3DS1(+) and KIR3DL1(+) NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection
  2. Alter, G.; Rihn, S.; Walter, K.; Nolting, A.; Martin, M.; Rosenberg, E. S.; Miller, J. S.; Carrington, M.; Altfeld, M.
  3. Journal of Virology. 2009 83(13): 6798-6805.
  1. 13.   Clinical Manifestations, Etiology, and Pathogenesis of the Hyper-IgE Syndromes
  2. Freeman, A. F.; Holland, S. M.
  3. Pediatric Research. 2009 65(5): 32R-37R.
  1. 14.   Discovery and Characterization of a Peptide Motif That Specifically Recognizes a Non-native Conformation of Human IgG Induced by Acidic pH Conditions
  2. Sakamoto, K.; Ito, Y.; Hatanaka, T.; Soni, P. B.; Mori, T.; Sugimura, K.
  3. Journal of Biological Chemistry. 2009 284(15): 9986-9993.
  1. 15.   Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses
  2. Ahlenstiel, G.; Martin, M. P.; Gao, X. J.; Carrington, M.; Rehermann, B.
  3. Journal of Clinical Investigation. 2008 118(3): 1017-1026.
  1. 16.   KIR-HLA intercourse in HIV disease
  2. Carrington, M.; Martin, M. P.; van Bergen, J.
  3. Trends in Microbiology. 2008 16(12): 620-627.
  1. 17.   STAT3 mutations in the hyper-IgE syndrome
  2. Holland, S. M.; DeLeo, F. R.; Elloumi, H. Z.; Hsu, A. P.; Uzel, G.; Brodsky, N.; Freeman, A. F.; Demidowich, A.; Davis, J.; Turner, M. L.; Anderson, V. L.; Darnell, D. N.; Welch, P. A.; Kuhns, D. B.; Frucht, D. M.; Malech, H. L.; Gallin, J. I.; Kobayashi, S. D.; Whitney, A. R.; Voyich, J. M.; Musser, J. M.; Woellner, C.; Schaffer, A. A.; Puck, J. M.; Grimbacher, B.
  3. New England Journal of Medicine. 2007, Oct; 357(16): 1608-1619.
  1. 18.   Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection
  2. Pascal, V.; Yamada, E.; Martin, M. P.; Alter, G.; Altfeld, M.; Metcalf, J. A.; Baseler, M. W.; Adelsberger, J. W.; Carrington, M.; Anderson, S. K.; McVicar, D. W.
  3. Journal of Immunology. 2007, Aug; 179(3): 1625-1633.
  1. 19.   Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
  2. Martin, M. P.; Qi, Y.; Gao, X. J.; Yamada, E.; Martin, J. N.; Pereyra, F.; Colombo, S.; Brown, E. E.; Shupert, W. L.; Phair, J.; Goedert, J. J.; Buchbinder, S.; Kirk, G. D.; Telenti, A.; Connors, M.; O'Brien, S. J.; Walker, B. D.; Parham, P.; Deeks, S. G.; McVicar, D. W.; Carrington, M.
  3. Nature Genetics. 2007, Jun; 39(6): 733-740.
  1. 20.   Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8(+) T cell epitopes
  2. Gillespie, G. M. A.; Bashirova, A.; Dong, T.; McVicar, D. W.; Rowland-Jones, S. L; Carrington, M.
  3. Aids Research and Human Retroviruses. 2007, Mar; 23(3): 451-455.
  1. 21.   Cutting edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B
  2. Thananchai, H.; Gillespie, G.; Martin, M. P.; Bashirova, A.; Yawata, N.; Yawata, M.; Easterbrook, P.; McVicar, D. W.; Maenaka, K.; Parham, P.; Carrington, M.; Dong, T.; Rowl, -Jones
  3. Journal of Immunology. 2007, Jan; 178(1): 33-37.
  1. 22.   KIR and disease: a model system or system of models?
  2. Khakoo, S. I.; Carrington, M.
  3. Immunological Reviews. 2006, Dec; 214: 186-201.
  1. 23.   The LRC haplotype project: a resource for killer immunoglobulin-like receptor-linked association studies
  2. Horton, R.; Coggill, P.; Miretti, M. M.; Sambrook, J. G.; Traherne, J. A.; Ward, R.; Sims, S.; Palmer, S.; Sehra, H.; Harrow, J.; Rogers, J.; Carrington, M.; Trowsdale, J.; Beck, S.
  3. Tissue Antigens. 2006, Nov; 68(5): 450-452.
  1. 24.   The impact of variation at the KIR gene cluster on human disease
  2. Carrington, M.; Martin, M. P.
  3. Immunobiology of Natural Killer Cell Receptors. 2006; 298 : 225-257.
  1. 25.   Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma
  2. Kovacic, M. B.; Martin, M.; Gao, X. J.; Fuksenko, T.; Chen, C. J.; Cheng, Y. J.; Chen, J. Y.; Apple, R.; Hildesheim, A.; Carrington, M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 1): 2673-2677.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel